BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29908639)

  • 1. A bioinformatics transcriptome meta-analysis highlights the importance of trophoblast differentiation in the pathology of hydatidiform moles.
    Desterke C; Slim R; Candelier JJ
    Placenta; 2018 May; 65():29-36. PubMed ID: 29908639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of leukemia inhibitory factor and insulin like growth factor-1 between normal pregnancies, partial hydatidiform moles and complete hydatidiform moles.
    Yucel Cicek OS; Hekimoglu ER; Turgal M; Atilla P; Cakar AN; Usubutun A; Beksac MS
    Placenta; 2018 Sep; 69():64-70. PubMed ID: 30213486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of HOX gene products in normal and abnormal trophoblastic tissue.
    Amesse LS; Moulton R; Zhang YM; Pfaff-Amesse T
    Gynecol Oncol; 2003 Sep; 90(3):512-8. PubMed ID: 13678718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New concepts in trophoblastic growth and differentiation with practical application for the diagnosis of gestational trophoblastic disease.
    Shih IM; Kurman RJ
    Verh Dtsch Ges Pathol; 1997; 81():266-72. PubMed ID: 9474880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered p16 and Bcl-2 expression reflects pathologic development in hydatidiform moles and choriocarcinoma.
    Candelier JJ; Frappart L; Yadaden T; Poaty H; Picard JY; Prévot S; Coullin P
    Pathol Oncol Res; 2013 Apr; 19(2):217-27. PubMed ID: 23065465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of human chorionic gonadotropin/human luteinizing hormone receptors in human gestational trophoblastic neoplasms.
    Lei ZM; Rao CV; Ackerman DM; Day TG
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1236-41. PubMed ID: 1592864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular mass polypeptide-2 in human trophoblast: over-expression in hydatidiform moles and possible role in trophoblast cell invasion.
    Fu JJ; Lin P; Lv XY; Yan XJ; Wang HX; Zhu C; Tsang BK; Yu XG; Wang H
    Placenta; 2009 Apr; 30(4):305-12. PubMed ID: 19217658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trophoblastic debris extruded from hydatidiform molar placentae activates endothelial cells: Possible relevance to the pathogenesis of preeclampsia.
    Zhao M; Yin Y; Wei J; Wu M; Yang C; Chen Q
    Placenta; 2016 Sep; 45():42-9. PubMed ID: 27577709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumor suppressor gastrokine-1 is expressed in placenta and contributes to the regulation of trophoblast migration.
    Fahlbusch FB; Ruebner M; Huebner H; Volkert G; Zuern C; Thiel F; Koch M; Menendez-Castro C; Wachter DL; Hartner A; Rascher W
    Placenta; 2013 Nov; 34(11):1027-35. PubMed ID: 23993393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 expression in placentas with hydropic change and hydatidiform moles.
    Cheville JC; Robinson RA; Benda JA
    Mod Pathol; 1996 Apr; 9(4):392-6. PubMed ID: 8729978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trophoblast proliferation rate does not predict progression to persistent gestational trophoblastic disease in complete hydatidiform mole.
    Jeffers MD; Richmond JA; Smith R
    Int J Gynecol Pathol; 1996 Jan; 15(1):34-8. PubMed ID: 8852444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
    Cui JQ; Shi YF; Zhou HJ; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of p57 marker in differential diagnosis of complete and partial mole - correlation with DNA analysis].
    Cierna Z; Palkovič M; Danihel Ml L; Danihel L; Repiská V; Vojtaššák J; Korbeľ M
    Cesk Patol; 2012 Oct; 48(4):218-21. PubMed ID: 23121032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrix metalloproteinase-2 and mutant p53 is increased in hydatidiform mole as compared with normal placenta.
    Petignat P; Laurini R; Goffin F; Bruchim I; Bischof P
    Int J Gynecol Cancer; 2006; 16(4):1679-84. PubMed ID: 16884384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The product of the imprinted gene IPL marks human villous cytotrophoblast and is lost in complete hydatidiform mole.
    Saxena A; Frank D; Panichkul P; Van den Veyver IB; Tycko B; Thaker H
    Placenta; 2003; 24(8-9):835-42. PubMed ID: 13129680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-21 Is Overexpressed in Hydatidiform Mole Tissues and Promotes Proliferation, Migration, and Invasion in Choriocarcinoma Cells.
    Wang YX; Zhao JR; Xu YY; Wu WB; Zhang HJ
    Int J Gynecol Cancer; 2017 Feb; 27(2):364-374. PubMed ID: 27922982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very early complete hydatidiform mole.
    Keep D; Zaragoza MV; Hassold T; Redline RW
    Hum Pathol; 1996 Jul; 27(7):708-13. PubMed ID: 8698316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases.
    Xue WC; Feng HC; Tsao SW; Chan KY; Ngan HY; Chiu PM; Maccalman CD; Cheung AN
    Int J Gynecol Cancer; 2003; 13(6):879-88. PubMed ID: 14675328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the p53 gene in trophoblastic cells in hydatidiform moles and normal human placentas.
    Cheung AN; Srivastava G; Chung LP; Ngan HY; Man TK; Liu YT; Chen WZ; Collins RJ; Wong LC; Ma HK
    J Reprod Med; 1994 Mar; 39(3):223-7. PubMed ID: 8035377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARgamma expression in normal human placenta, hydatidiform mole and choriocarcinoma.
    Capparuccia L; Marzioni D; Giordano A; Fazioli F; De Nictolis M; Busso N; Todros T; Castellucci M
    Mol Hum Reprod; 2002 Jun; 8(6):574-9. PubMed ID: 12029076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.